| Identification | Back Directory | [Name]
1-Propanamine, 2-[4-[(3β)-cholest-5-en-3-yloxy]butoxy]-N,N-dimethyl-3-[(9Z,12Z)-9,12-octadecadien-1-yloxy]- | [CAS]
908860-82-2 | [Synonyms]
1-Propanamine, 2-[4-[(3β)-cholest-5-en-3-yloxy]butoxy]-N,N-dimethyl-3-[(9Z,12Z)-9,12-octadecadien-1-yloxy]- | [Molecular Formula]
C54H97NO3 | [MOL File]
908860-82-2.mol | [Molecular Weight]
808.35 |
| Chemical Properties | Back Directory | [Boiling point ]
775.5±60.0 °C(Predicted) | [density ]
0.96±0.1 g/cm3(Predicted) | [storage temp. ]
4°C, away from moisture and light | [solubility ]
DMSO : 140 mg/mL (173.19 mM; Need ultrasonic) | [form ]
Viscous Liquid | [pka]
8?+-.0.28(Predicted) | [color ]
Light yellow to yellow |
| Hazard Information | Back Directory | [Uses]
CLinDMA, a cationic lipid, can cause inflammatory response. CLinDMA can be used for the synthesis LNP201. LNP201 is a liposome assembly for systemic delivery of siRNA[1]. | [storage]
4°C, away from moisture and light | [References]
[1] Abrams MT, et al. Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment. Mol Ther. 2010;18(1):171-180. DOI:10.1038/mt.2009.208 |
|
| Company Name: |
DC Chemicals
|
| Tel: |
021-58447131 13564518121 |
| Website: |
https://www.chemicalbook.com/ShowSupplierProductsList927327/0.htm |
|